ADAR1 Capital Management reports acquisition of $53,691.3221 in NextCure common shares
NXTC•ADAR1 Capital Management reported purchases of 10,851 NextCure shares, increasing indirect beneficial ownership to 733,270 shares. The purchases were made at prices of $4.8294, $5.0344 and $5.0953 per share.
